Zydus Wellness Completes Acquisition of 98.14% Equity in Naturell (India) Private Limited
Team Finance Saathi
30/Nov/2024

What's covered under the Article:
- Zydus Wellness acquires 98.14% equity stake in Naturell (India) Private Limited, finalizing a major acquisition.
- The acquisition follows a Share Purchase Agreement with Naturell’s promoters and other stakeholders.
- Zydus Wellness plans to acquire the remaining 1.86% stake in the near future to complete the transaction.
Zydus Wellness Limited has officially completed the acquisition of a 98.14% equity share in Naturell (India) Private Limited, as per the Share Purchase Agreement signed with the promoters and other shareholders of Naturell. This acquisition, which was first announced in a letter dated October 30, 2024, marks a significant milestone in Zydus Wellness's corporate growth strategy. The deal was finalized on November 29, 2024, with Zydus Wellness purchasing the majority stake from the Sellers of Naturell.
The acquisition of 98.14% equity in Naturell (India) Private Limited brings the company a step closer to completing the full acquisition of Naturell. Zydus Wellness is in the process of finalizing the acquisition of the remaining 1.86% equity share capital, which is expected to be completed in the near future. This acquisition will allow Zydus Wellness to expand its footprint in the health and wellness segment, further enhancing its product portfolio.
Naturell (India) Private Limited is a key player in the wellness industry, known for its range of products that complement the growing consumer demand for healthier living options. The strategic acquisition aligns with Zydus Wellness's vision to strengthen its presence in the health and wellness sector and diversify its product offerings. The move will also help Zydus Wellness tap into the growing market for nutritional supplements and functional foods, areas where Naturell has built strong expertise.
The acquisition has been executed in compliance with the SEBI Listing Regulations and follows the proper regulatory framework. Zydus Wellness has provided an update to the stock exchanges, in line with the disclosure requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with a reference to their earlier communication dated October 30, 2024.
The Upcoming IPOs in this week and coming weeks are Property Share REIT, Nisus Finance, Emerald Tyre Manufacturers, Rosmerta Digital and Avanse Financial.
The Current active IPO is Ganesh Infraworld, Suraksha Diagnostic, Agarwal Toughened.
This strategic acquisition reflects Zydus Wellness’s commitment to expanding its business through strategic investments, acquisitions, and partnerships. By acquiring Naturell, Zydus Wellness aims to enhance its portfolio and better position itself in the fast-growing wellness market.
As Zydus Wellness continues to pursue its growth objectives, this acquisition of Naturell (India) Private Limited will undoubtedly serve as a stepping stone towards its goal of becoming a leading player in the wellness industry. The finalization of the remaining 1.86% stake will ensure that Zydus Wellness secures full control over Naturell, enabling synergies and greater operational efficiencies moving forward.
For more information on Zydus Wellness's latest acquisitions and other corporate developments, visit Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News- Finance Saathi.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.
Start your Stock Market Journey and Apply in IPO by Opening a Free Demat Account in Choice Broking FinX.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.